E.E. Geduld’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

E.E. Geduld’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-25,000	Closed	-$39K	–	238
2015 Q3	$39K	Hold	25,000	–	–	0.04%	160
2015 Q2	$43K	Hold	25,000	–	–	0.03%	244
2015 Q1	$53K	Hold	25,000	–	–	0.04%	222
2014 Q4	$34K	Hold	25,000	–	–	0.02%	214
2014 Q3	$21K	Hold	25,000	–	–	0.01%	218
2014 Q2	$57K	Sell	25,000 -25,000	-50%	-$62.1K	0.04%	247
2014 Q1	$150K	Hold	50,000	–	–	0.08%	200
2013 Q4	$157K	Hold	50,000	–	–	0.08%	217
2013 Q3	$138K	Sell	50,000 -15,000	-23%	-$40.6K	0.08%	202
2013 Q2	$162K	Buy	+65,000	New	+$341K	0.12%	174

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NPC

National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

E.E. Geduld's ECTE Position: Q4 2015 in Review

E.E. Geduld sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q4 2015, closing a stake of 25,000 shares — an estimated $39K sold.

E.E. Geduld first reported a position in ECTE in Q2 2013 and held it in 10 quarters. The position peaked at $162K in Q2 2013. 18 funds tracked by Wall St. Rank hold ECTE as of Q4 2015.

E.E. Geduld reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q4 2015 after selling out during the quarter.
E.E. Geduld sold 25,000 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q4 2015, an estimated $39K.
E.E. Geduld first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 10 quarters.
E.E. Geduld's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $162K in Q2 2013.
18 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q4 2015.

Based on E.E. Geduld's 13F filing for Q4 2015, filed 2 Feb 2016.